Home / Anti-infectives / Meningococcus B, Multicomponent Vaccine
ATC J07AH09 · Vaccines
Meningococcus B, Multicomponent Vaccine shortage
As of 31 Oct 2026, Meningococcus B, Multicomponent Vaccine has a reported shortage in 1 of the 5 countries we track (Austria), covering 1 product.
Countries1/5
Products1packs or presentations
Short since27 Aug 20262 months ago
Earliest return31 Dec 2026company estimate
No return date0products
Main reasonManufacturing problem
Timeline
Austria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Bexsero Injektionssuspension in Fertigspritze Impfstoff gegen Meningokokken der Gruppe B (rDNA, Komponenten, adsorbiert), 1 Stück limited | Glaxosmithkline Vaccines S.r.l. | 27 Aug 2026 | 31 Dec 2026 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.